The FDA, urged to avoid controversy, creates a new headac...
Recent decisions at the FDA threaten to turn its disagreements with the drugmaker UniQure into another political headache for the Trump a...
What’s Happening
Alright so Recent decisions at the FDA threaten to turn its disagreements with the drugmaker UniQure into another political headache for the Trump administration.
Adams Biotech Scorecard Adams Biotech Scorecard STAT Plus: The extremism of the FDAs Marks and Prasad has come with costs By Adam Feuerstein Adams Biotech Scorecard Adams Biotech Scorecard STAT Plus: Xenons seizure drug study reads out soon. (we’re not making this up)
Heres what to expect By Adam Feuerstein Adams Biotech Scorecard Adams Biotech Scorecard STAT Plus: What to expect from Gossamer Bios late-stage lung disease study By Adam Feuerstein Adams Biotech Scorecard Adams Biotech Scorecard STAT Plus: The old Vinay Prasad never left.
Why This Matters
Medical professionals are taking note of this development.
This is the kind of health news that affects everyday decisions.
The Bottom Line
This story is still developing, and we’ll keep you updated as more info drops.
Thoughts? Drop them below.
Daily briefing
Get the next useful briefing
If this story was worth your time, the next one should be too. Get the daily briefing in one clean email.
Reader reaction
